GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Bumrungrad Hospital PCL (FRA:BZ7A) » Definitions » Research & Development

Bumrungrad Hospital PCL (FRA:BZ7A) Research & Development : €0.0 Mil (TTM As of Sep. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Bumrungrad Hospital PCL Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Bumrungrad Hospital PCL's Research & Development for the three months ended in Sep. 2024 was €0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Sep. 2024 was €0.0 Mil.


Bumrungrad Hospital PCL Research & Development Historical Data

The historical data trend for Bumrungrad Hospital PCL's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bumrungrad Hospital PCL Research & Development Chart

Bumrungrad Hospital PCL Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Bumrungrad Hospital PCL Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Bumrungrad Hospital PCL Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bumrungrad Hospital PCL  (FRA:BZ7A) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Bumrungrad Hospital PCL Research & Development Related Terms

Thank you for viewing the detailed overview of Bumrungrad Hospital PCL's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Bumrungrad Hospital PCL Business Description

Traded in Other Exchanges
Address
33 Soi 3 (Nana Nua) Sukhumvit Road, Klongtoey Nua Sub District, Wattana District, Bangkok, THA, 10110
Bumrungrad Hospital PCL operates a private hospital business in Bangkok. It is a healthcare provider in Thailand and the Southeast Asian region, providing complete healthcare services for both outpatients and inpatients. The company is the owner and operator of multiple healthcare-related entities. The company has only one main reportable operating segment, which is the hospital and health care center business, and the geographical area of its operations is Thailand.

Bumrungrad Hospital PCL Headlines

No Headlines